Pericytes play a key role in the development of cerebral microcirculation. The exact role of pericytes in the neurovascular unit in the adult brain and during brain aging remains, however, elusive. Using adult viable pericyte-deficient mice, we show that pericyte loss leads to brain vascular damage by two parallel pathways: (1) reduction in brain microcirculation causing diminished brain capillary perfusion, cerebral blood flow, and cerebral blood flow responses to brain activation that ultimately mediates chronic perfusion stress and hypoxia, and (2) blood-brain barrier breakdown associated with brain accumulation of serum proteins and several vasculotoxic and/or neurotoxic macromolecules ultimately leading to secondary neuronal degenerative changes. We show that age-dependent vascular damage in pericyte-deficient mice precedes neuronal degenerative changes, learning and memory impairment, and the neuroinflammatory response. Thus, pericytes control key neurovascular functions that are necessary for proper neuronal structure and function, and pericyte loss results in a progressive age-dependent vascular-mediated neurodegeneration.
INTRODUCTION
An intact functional neurovascular unit is comprised of endothelial cells, pericytes, glia, and neurons (Zlokovic, 2008; Lo and Rosenberg, 2009; Segura et al., 2009; Iadecola, 2010) . Pericytes ensheath the capillary wall, making direct contacts with endothelial cells (Armulik et al., 2005; Díaz-Flores et al., 2009 ). Endothelial-secreted platelet-derived growth factor B (PDGF-B) binds to the platelet-derived growth factor receptor beta (PDGFRb) on pericytes, initiating multiple signal transduction pathways regulating proliferation, migration, and recruitment of pericytes to the vascular wall (Armulik et al., 2005; Lebrin et al., 2010) . Much of the insight into brain pericyte biology arose from developmental studies and the analysis of pericyte-deficient transgenic mice with disrupted PDGF-B/PDGFRb signaling (Lindahl et al., 1997; Lindblom et al., 2003; Tallquist et al., 2003; Gaengel et al., 2009 ).
In the developing central nervous system (CNS), pericyte loss in embryonic lethal PDGF-B null and PDGFRb null mice leads to endothelial cell hyperplasia, suggesting that pericytes control endothelial cell number and microvessel architecture but do not determine microvessel density, length, or branching (Lindahl et al., 1997; Hellströ m et al., 1999 Hellströ m et al., , 2001 . Earlier in vitro studies have also demonstrated that pericytes inhibit endothelial cell proliferation (Orlidge and D'Amore, 1987; Hirschi et al., 1999) . Endothelial-specific PDGF-B deletion results in viable mice that develop diabetic-like proliferative retinopathy, characterized by an increased number of acellular regressing capillaries (Enge et al., 2002) . In experimental models of diabetic retinopathy, hyperglycemia has been found to lead to diminished PDGFRb signaling resulting in pericyte apoptosis (Geraldes et al., 2009 ), increased endothelial cell proliferation, and increased numbers of acellular capillaries in pericyte-deficient Pdgfb +/À mice . In contrast, studies focusing on tumor angiogenesis have suggested that pericyte loss may indeed lead to endothelial apoptosis (Song et al., 2005) . Therefore, it is unclear as to what role pericytes may play in modulating the adult cerebrovascular microcirculatory structure and/or function.
In the adult brain, pericytes modulate capillary diameter by constricting the vascular wall (Peppiatt et al., 2006) , a process which during ischemia may obstruct capillary blood flow (Yemisci et al., 2009; Vates et al., 2010) . Still, relatively little is known about the role of pericytes in vascular maintenance in the adult and aging brain. It is also unknown whether pericyte degeneration can influence the neuronal phenotype. Using two different adult viable pericyte-deficient mouse strains with variable degrees of pericyte loss (Tallquist et al., 2003; Winkler et al., 2010) , we have investigated whether pericyte loss in the adult brain and during aging can influence brain capillary density, resting cerebral blood flow (CBF), CBF response to brain activation, and blood-brain barrier (BBB) integrity to serum proteins and blood-derived potentially cytotoxic and/or neurotoxic molecules. We have also studied the effects of an age-dependent pericyte loss and resulting hemodynamic (C) Age-dependent loss of pericyte coverage in the cortex and hippocampus of 1-, 6-to 8-, and 14-to 16-month-old Pdgfrb +/À mice (black bars) and in 6-to 8-month-old F7 mice (gray bars) compared to age-matched Pdgfrb +/+ controls (white bars). Pericyte coverage was determined as a percentage (%) of desmin-positive pericyte surface area covering lectin-positive capillary surface area that was arbitrarily taken as 100%. Total of 36 and 24 randomly chosen fields (420 3 420 mm) from six nonadjacent cortical and hippocampal sections, respectively, were analyzed per mouse. Mean ± SEM, n = 6 mice per group; *p < 0.05 or **p < 0.01 by one-way ANOVA.
disturbances on neuronal structure and function and the onset of neuroinflammation.
RESULTS

Reductions in Cerebral Microcirculation and Blood Flow in Pericyte-Deficient Mice
We have recently reported that PDGFRb is exclusively expressed in pericytes, and not in neurons, astrocytes, or endothelial cells, in different brain regions of adult viable 129S1/SvlmJ mice with normal or deficient PDGFRb signaling . Therefore, a genetic disruption of PDGFRb signaling in Pdgfrb +/À mice and the F7 homozygous mutants with two hypomorphic alleles of Pdgfrb exhibiting $35% and $65% pericyte loss in the embryonic CNS, respectively (Tallquist et al., 2003) , results in a primary pericyte-specific insult.
Using three-color confocal imaging analysis for PDGFRb and the well-established pericyte markers chondroitin sulfate proteoglycan NG2 (Armulik et al., 2005; Peppiatt et al., 2006; Pfister et al., 2008; Yemisci et al., 2009 ) and desmin (Hellströ m et al., 1999; Tallquist et al., 2003; Song et al., 2005; Kokovay et al., 2006) , along with endothelial-specific Lycopersicon esculentum lectin fluorescent staining to visualize brain capillary profiles, we show that PDGFRb colocalizes with pericytes on brain capillaries, as illustrated in cortical layer II and hippocampal CA1 regions in 6-month-old Pdgfrb +/+ control mice (Figures S1A-S1C, available online), as reported . There was no detectable colocalization of PDGFRb with the neurofilament-H marker of neuronal cell processes (SMI-32) or the neuronal-specific nuclear antigen A60 (NeuN), as illustrated in cortical layers II and III in 2-month-old Pdgfrb +/+ and Pdgfrb +/À mice, respectively ( Figure 1A ), which corroborates a previous report showing that PDGRFb is not expressed in neurons in viable F7 mutants . Hematoxylin and eosin staining provides a low-magnification view of a control mouse cerebral hemisphere adjacent to sections subsequently utilized for all fluorescent imaging experiments ( Figure S1A ). Using dual immunostaining for desmin-and lectin-positive brain capillary profiles, we show an age-dependent progressive loss of pericyte coverage in the cortex ( Figures 1B-1C ) and hippocampus ( Figure 1C) 1D ) and CD31-positive (Figures S1D and S1F) capillary profiles. We also show an age-dependent progressive reduction in Pdgfrb +/À mice of lectin-positive and/or CD31-positive microvascular profiles in the cortex and hippocampus by 30%-34% and 50%-52% at 6-8 and 14-16 months, respectively (Figures 1B and 1D and Figures S1D and S1F) .
There was a strong positive correlation between an agedependent loss in both pericyte coverage and pericyte number and microvascular reductions ( Figure 1E and Figure S1G ), indicating that pericyte degeneration is associated with progressive age-dependent microvascular degeneration. This was corroborated in 6-to 8-month-old F7 mutant mice and Pdgfrb +/À mice by showing that F7 mutants, which exhibit a significantly greater, i.e., $60%, pericyte loss in the cortex and hippocampus than Pdgfrb +/À mice ( Figure 1C ), had significantly greater 45%-53% loss in the microvascular length in the cortex and hippocampus compared to 30%-34% reduction in Pdgfrb +/À mice ( Figure 1D ).
Using three-color immunostaining for pericytes and endothelial cells and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining for DNA fragmentation suggestive of apoptotic and/or necrotic cell death, we show that Pdgfrb +/À and F7 mice, but not the control Pdgfrb +/+ mice, occasionally display degenerating pericytes associated with degenerating TUNEL-positive capillary endothelium, as illustrated in the cortex of 1-and 6-month-old Pdgfrb +/À and 6-month-old F7 mice ( Figure 1F ). Using in vivo multiphoton microscopy imaging of fluoresceinconjugated mega-dextran (MW = 2,000,000 Da), we generated 3D 0.5 mm Z stack cortical angiograms in Pdgfrb +/À mice and age-matched controls to find out whether microvascular reductions determined by histological quantification ( Figure 1D and Figure S1F ) reflect a capillary perfusion deficit in vivo. The analysis of angiograms has indicated an age-dependent reduction in the length of perfused cortical microvessels, i.e., by 18%, 30%, and 47% at 1, 6-8, and 14-16 months of age, respectively (Figures 2A-2B ). These results were comparable to the reductions determined by histological analysis, indicating no discrepancy between the two methods. There was a strong positive correlation between age-dependent reductions in pericyte loss and perfused capillary length ( Figure 2C ). The F7 mutant mice at 6-8 months of age exhibited significantly greater reduction in the perfused cortical vascular length compared to 6-to (A) Perfusion of cortical microvessels studied by in vivo multiphoton microscopy analysis of fluorescein-conjugated mega-dextran (MW = 2,000,000; green) in an 8-month-old Pdgfrb +/+ mouse, and 1-, 8-, and 16-month-old Pdgfrb +/À mice.
(B) Quantification of perfused capillary length from angiograms obtained as in (A). in 1-, 6-to 8-, and 14-to 16-month-old Pdgfrb +/+ mice (white bars) and Pdgfrb +/À mice (black bars), and in 6-to 8-month-old F7 mice (gray bars). Two to three angiograms were analyzed per mouse.
(C) Positive correlation between age-dependent reductions of brain capillary perfusion and desmin-positive pericyte coverage of cortical capillaries in Pdgfrb +/À mice. Single data points were from 1-(red), 6-to 8-(blue), and 14-to 16-month-old (black) Pdgfrb +/À mice (n = 18). r = Pearson's coefficient.
(D) IAP autoradiography of the CBF in an 8-month-old Pdgfrb +/+ mouse, 1-and 8-month-old Pdgfrb +/À mice and an 8-month-old F7 mouse.
(E) Local CBF determined with 14 C-IAP autoradiography as in (D). in 1-, 6-to 8-, and 14-to 16-month-old Pdgfrb +/+ mice (white bars) and Pdgfrb +/À mice (black bars), and in 6-to 8-month-old F7 mice (gray bars). See Table S1 . (F) CBF responses to whisker-barrel cortex vibrissal stimulus (% increase from basal values) in 1-, 6-to 8-, and 14-to 16-month-old Pdgfrb +/+ mice (white bars)
and Pdgfrb +/À mice (black bars).
(G) Positive correlation between diminished CBF responses to a stimulus and an age-dependent loss of pericyte coverage of cortical capillaries in Pdgfrb +/À mice.
Single data points were from 1-(red), 6-to 8-(blue), and 14-to 16-month-old (black) Pdgfrb +/À mice (n = 18). r = Pearson's coefficient.
In (B, C, E, and F) mean ± SEM, n = 6 mice per group; *p < 0.05 or **p < 0.01 by one-way ANOVA.
8-month-old Pdgfrb +/À mice, i.e., 48% of controls compared to 30% of controls, respectively ( Figure 2B ), consistent with significantly greater pericyte degeneration. In these studies, imaging of perfused capillaries was accomplished within 40 min of the cranial window surgery before any significant inflammation or gliosis is present (see Supplemental Experimental Procedures).
Given that regional brain capillary density correlates with blood flow (Zlokovic, 2008) , we hypothesized that pericyte-deficient mice will have diminished resting CBF.
14 C-iodoantipyrine quantitative autoradiography revealed significant (23%-24%, 33%-37%, and 48%-50%) age-dependent reductions in the local CBF in the cortex and hippocampus of 1-, 6-to 8-, and 14-to 16-month-old Pdgfrb +/À mice compared to age-matched controls, respectively ( Figures 2D-E) . The F7 mutants at 6-8 months of age had greater CBF reductions in the cortex and hippocamus than 6-to 8-month-old Pdgfrb +/À mice, i.e., 49% and 41%, respectively ( Figure 2E ). Significant CBF reductions were found in other studied brain regions of pericyte-deficient mice (Table S1 ). Laser Doppler flowmetry showed diminished CBF responses to whisker-barrel cortex vibrissal stimulation in 1-, 6-to 8-, and 14-to 16-month-old Pdgfrb +/À mice to 27%, 21%, and 12% of basal values, respectively, compared to 32%, 34%, and 31% in the corresponding age-matched controls, respectively ( Figure 2F ). There was a significant positive correlation between the loss of pericyte coverage and diminished CBF responses during aging of Pdgfrb +/À mice ( Figure 2G ). The observed dysregulated CBF response in pericyte-deficient mice is consistent with previous findings, suggesting that pericytes participate in the control of brain capillary diameter in response to a stimulus (Peppiatt et al., 2006) .
BBB Breakdown in Pericyte-Deficient Mice
Early electron microscopy studies have shown that pericytes prevent entry of circulating exogenous horseradish peroxidase into the brain, suggesting pericytes are part of the BBB for macromolecules (reviewed in Díaz-Flores et al., 2009) . Whether degenerating pericytes in the aging brain can maintain the BBB in vivo against endogenous circulating macromolecules, some of which are potentially cytotoxic and/or neurotoxic is, however, unknown. To test this hypothesis, we studied whether plasma-derived proteins accumulate in the brains of pericytedeficient mice. Immunostaining for plasma-derived immunoglobulin G (IgG) and endothelial lectin, performed as we described (Zhong et al., 2008) , revealed significant perivascular IgG deposits and >3-fold increase in IgG accumulation in the hippocampus and cortex in 1-month-old Pdgfrb +/À mice compared to controls ( Figures 3A and 3B and Figure S2A ). There was a progressive BBB breakdown to IgG resulting in approximately 8-to 10-fold, and 20-to 25-fold greater IgG perivascular accumulation in the hippocampus and cortex of 6-to 8-and 14-to 16-month-old Pdgfrb +/À mice compared to age-matched controls, respectively, and a 16-to 18-fold increase in the hippocampus and cortex in 6-to 8-month-old F7 mutants ( Figure 3C and Figure S2B ). We also show a significant negative correlation between the perivascular IgG brain accumulation and pericyte coverage in Pdgfrb +/À mice ( Figure 3D and Figure S2C ).
In contrast, there was no detectable IgG leakage in control mice. High-resolution confocal microscopy confirmed the IgG perivascular accumulation around capillaries lacking pericyte coverage and in brain endothelium in pericyte-deficient mice ( Figure 3E ). In mice exhibiting substantial loss of pericytes, the IgG accumulates were also found in some remaining pericytes, as illustrated in an 8-month-old F7 mouse ( Figure 3F ), in contrast to controls. Pdgfrb +/À mice exhibited an age-dependent increase in perivascular fibrin ( Figures 4A-4C) , which was shown to accelerate neurovascular damage (Paul et al., 2007) . Quantification of perivascular fibrin deposits in Pdgfrb +/À mice compared to controls indicated 6-, 10-, and 46-fold increase at 1, 6-8, and 14-16 months of age, respectively, as shown in the cortex (Figures 4A-4C) , and similar age-dependent increases in the hippocampus ( Figures S2D-S2F ). An increased fibrin leakage of approximately 25-to 30-fold was found in the cortex and hippocampus, in 6-to 8-month-old F7 mutants ( Figure 4C ). As for IgG, there was a significant negative correlation between fibrin perivascular accumulation in brain and pericyte coverage ( Figure 4D and Figure S2F ). Fibrin accumulation was particularly abundant around brain capillaries lacking pericyte coverage ( Figure 4E ). Fibrin was also found in endothelial cells (Figure 4E) and pericytes, as shown in F7 mice ( Figure 4F ), but was leaking from the adjacent capillaries without pericyte coverage, as illustrated in Figure 4F (lower right corner).
To determine whether loss of pericytes can lead to pathological accumulations of neurotoxic macromolecules, we studied the brains of 6-to 8-month-old Pdgfrb +/À and F7 mice for
(1) hemosiderin deposits reflecting extravasation of the red blood cells with accumulation of hemoglobin-derived neurotoxic products such as iron that damages neurons by generating reactive oxygen species (Zhong et al., 2009 ); (2) accumulation of thrombin, which at higher concentrations mediates neurotoxicity and memory impairment (Mhatre et al., 2004) and vascular damage and BBB disruption (Chen et al., 2010) ; and (3) plasmin (derived from circulating plasminogen), which catalyzes the degradation of neuronal laminin promoting neuronal injury (Chen and Strickland, 1997) . As shown by Prussian blue staining, Pdgfrb +/À mice and the F7 mutants exhibited 5-and 8-fold greater hemosiderin accumulation than controls, respectively ( Figure 4G ). Immunoblot analysis of capillary-depleted brains revealed that Pdgfrb +/À mice and the F7 mutants accumulate 21 and 46 times more thrombin than controls, respectively ( Figure 4H , upper lane, left graph). These mice also showed 17 and 39 times greater accumulation of plasmin compared to controls, respectively, accompanied with a proportional reduction in laminin content in capillary-depleted brain ( Figure 4H , middle and lower panels and middle and right graphs). These findings show that pericyte loss leads to BBB breakdown and accumulation of vasculotoxic and neurotoxic macromolecules in brain that is proportional to the degree of pericyte loss.
To test whether the BBB is open to acutely administered exogenous macromolecules, we performed in vivo time-lapse multiphoton imaging of the cortical vessels in layers II and III with intravenous medium-size macromolecular dextran (MW = 40,000 Da, tetramethylrhodamine [TMR] conjugated) in 1-, 6-to 8-, and 14-to 16-month-old Pdgfrb +/À mice. In contrast to age-matched controls with an intact BBB to TMR-dextran over the 30 min period of imaging, there was a rapid age-dependent in vivo leakage of TMR-dextran in Pdgfrb +/À mice in all age groups, beginning at 10 min and peaking at 30 min ( Figure 5A ). The leakage was obvious in 1-month-old Pdgfrb +/À mice indicating $3-fold increase in the cerebrovascular permeability (i.e., the permeability surface area product [PS]) compared to controls ( Figure 5B ), and 19-and 54-fold greater PS value in 6-to 8-and 14-to 16-month-old Pdgfrb +/À mice compared to their respective age-matched controls ( Figure 5C ). There was a significant $30-fold increase in the PS product to TMR-dextran in the F7 mutants ( Figure 5C ). The degree of BBB leakage to dextran in Pdgfrb +/À mice was proportional to the degree of pericyte loss ( Figure 5D ).
To increase confidence in our in vivo time-lapse multiphoton data and find out whether an acute 30 min cranial window procedure for the multiphoton imaging affects BBB permeability measurements, we next used a noninvasive fluorometric analysis, which did not require the cranial window surgical manipulation, to determine BBB permeability to TMR-dextran in 6-to 8-month-old Pdgfrb +/À mice and F7 mutants. This noninvasive fluorescent technique confirmed an increased BBB permeability to TMR-dextran (MW = 40,000 Da) in Pdgfrb +/À mice and F7 mutants in the cortex by 18-and 30-fold, respectively ( Figure 5E ). These results were comparable to the results obtained by in vivo multiphoton imaging, indicating no discrepancy between the methods. The BBB breakdown was also seen in the hippocampus ( Figure 5E ) and other brain regions (data not shown).
To determine the molecular size limit of solutes that can penetrate through the abnormal BBB in the mutant mice, we studied the BBB permeability to Cy3-IgG (MW = 150,000 Da), FITC-dextran (MW = 500,000 Da), and fluorescein-megadextran (MW = 2,000,000 Da) in 6-to 8-month-old Pdgfrb +/+ , Pdgfrb +/À , and F7 mice by using a noninvasive fluorometric method. These measurements have indicated that the BBB is open to molecules ranging from 40,000 to 500,000 Da; the molecular size limit was found to be between 500,000 and 2,000,000 Da ( Figure 5E ). These data suggest that molecules such as thrombin (MW = 36,000 Da) and fibrinogen (MW = 340,000 Da) can enter freely from the circulation into the brain across the damaged BBB and accumulate in the brain. BBB breakdown within a short period of time, as observed as in the present BBB permeability studies, typically indicates disruption of the BBB tight junctions (TJ) (Zlokovic, 2008) . TJ proteins seal the endothelial barrier preventing uncontrolled entry of solutes from blood to brain. Their expression is reduced in stroke and several neurodegenerative disorders leading to the BBB breakdown (Zlokovic, 2008) . TJ appearance in the embryonic CNS is associated with pericyte coverage of the endothelium (Bauer et al., 1993) , and pericytes enhance the endothelial barrier integrity in vitro (Nakagawa et al., 2007; Krö ll et al., 2009 ). Therefore, we tested whether TJ expression is altered in pericyte-deficient mice. Immunoblot analysis of TJ proteins in isolated brain capillaries revealed an age-dependent reduction in ZO-1 and occludin expression in Pdgfrb +/À mice compared to controls by 40%-50% and 80% in 6-to 8-and 14-to 16-month-old mice, respectively ( Figure 5F -H). A comparison of ZO-1, occludin, and claudin-5 expression in 6-to 8-monthold Pdgfrb +/À mice and F7 mutants has revealed significant reductions by 48% and 37%, 42% and 80%, and 69% and 70%, respectively, compared to controls (Figures S3A and S3B) . These findings were corroborated by immunostaining for the TJ protein ZO-1 ( Figures S3C and S3D ) and the adherens junction protein VE-cadherin ( Figures S3E and S3F ). Pericytedeficient mice also exhibited reductions in the capillary basement membrane proteins collagen IV and vascular laminin, as shown by immunoblotting of the isolated brain microvessels (Figures S3G and S3H) , consistent with the role of pericytes in basement membrane formation (Díaz-Flores et al., 2009 ). In addition, accumulation of different endogenous macromolecules in brain endothelium of pericyte-deficient mice as shown for IgG (Figures 3E and 3F) and fibrinogen/fibrin (Figures 4E and 4F) might reflect enhanced bulk flow transcytosis that may also contribute to the observed BBB disruption.
To determine whether accumulation of blood-derived components in the brain is primarily related to pericyte deficiency and not to perfusion stress, we studied mice with a single deletion of the mesenchyme homeobox gene-2 allele (Meox2 +/À ) exhibiting a significant perfusion deficit with 45%-50% reductions in capillary density and resting CBF, respectively, as we reported (Wu et al., 2005) , but with normal pericyte coverage of microvessels ( Figures S4A and S4B) . In contrast to F7 or Pdgfrb +/À mice,
Meox2
+/À mice at a comparable age did not show any extravascular IgG or fibrin deposits ( Figure S4C ) and expressed normal levels of TJ proteins ( Figure S4D ) in spite of significant (p < 0.05) 45% and 48% reductions in the microvascular length ( Figure S4E ) and brain perfusion (data not shown), as reported (Wu et al., 2005) . Studies in Meox2 +/À mice confirmed that the BBB breakdown in pericyte-deficient mice is not related to perfusion stress and is mediated by pericyte loss. Meox2 +/À mice had normal arterial vascular reactivity and normal thickness of the vascular smooth muscle cells layer in the pial arteries (Wu et al., 2005) , consistent with unaltered CBF responses to stimulation ( Figure S4F ) further supporting that pericytes are required for hemodynamic responses to brain activation.
Dual fluorescent staining of lectin-positive endothelium and aquaporin 4 or a-syntrophin (SNTA1), markers of the astrocytic end-foot processes enwrapping brain microvessels, and glial fibrillary acidic protein (Zlokovic, 2008) , failed to show changes in astrocyte coverage of microvessels and astrocyte number in pericyte-deficient mice, respectively ( Figure S5 ). These findings are consistent with earlier studies demonstrating that TJ formation at the BBB does not require contact with astrocyte foot processes on capillary surface and is not affected in areas lacking astrocytes (reviewed in Zlokovic, 2008) .
Neurodegeneration and Impairments in Learning and Memory in Pericyte-Deficient Mice
To determine whether loss of pericytes causing alterations in microvascular function and BBB integrity was sufficient to induce irreversible neuronal injury, we studied neuronal morphology and behavior.
Using Golgi-Cox staining, we failed to detect any structural changes in neurons in the CA1 hippocampal region (or cortex, data not shown) in 1-month-old Pdgfrb +/À mice (Figures 6A-6E). However, there was a significant age-dependent loss of dendritic length, spine density, and spine length in the hippocampus of Pdgfrb +/À mice at 6-8 and 14-16 months of age by 32%, 30%, and 18%, and 55%, 58%, and 56%, respectively ( Figures 6A-6E) . A comparison of 6-to 8-month-old Pdgfrb (B and C) Quantification of fibrin extravascular deposits in the cortex of 1-month-old Pdgfrb +/+ (white bar) and Pdgfrb +/À mice (black bar) (B), and 6-to 8-and 14-to 16-month-old Pdgfrb +/+ (white bars) and Pdgfrb +/À mice (black bar), and 6-to 8-month-old F7 mice (gray bar) (C). In B and C, 36 randomly chosen fields (420 3 420 mm) in the cortex were analyzed from six nonadjacent sections per mouse. Values are mean ± SEM, n = 6 mice per group; *p < 0.05 or **p < 0.01 by one-way ANOVA (see Figure S2 ). loss in 1-month-old Pdgfrb +/À mice, and a 10% and 27% loss in 6-to 8-month-old Pdgfrb +/À and F7 mice, respectively (Figure 6G) . Pdgfrb +/À 14-to 16-month-old mice had a significantly greater (48%) loss of neurons in the CA1 region compared to controls ( Figure 6G ). Confocal microscopy analysis for TUNEL, neuronal marker NeuN and thrombin in 6-month-old and older Pdgfrb +/À mice indicated sporadically a colocalization of the cytoplasmic thrombin accumulations and TUNEL-positive dying neurons, as illustrated in an 8-month-old Pdgfrb +/À mouse compared to negative staining for TUNEL and thrombin in a control Pdgfrb +/+ mouse ( Figure 6H ). Using the Hypoxyprobe-1 (pimonidazole), we found that brains of 6-to 8-month-old Pdgfrb +/À and F7 mice are hypoxic compared to control Pdgfrb +/+ mice ( Figure 7A ).The hypoxic area expressed as a percentage of total tissue area in the hippocampus and cortex was $1.5% in control Pdgfrb +/+ mice compared to 6%-7% in Pdgfrb +/À mice and 9%-11% in F7 mutants ( Figure 7B ). Chronic hypoxic changes in brain tissue probably aggravate neuronal injury, as shown in models of combined ischemic/hypoxic brain injury (Ten et al., 2004) . No significant hypoxic changes were found in young pericyte-deficient mice (data not shown). It is of note that the brains of pericyte-deficient mice were perfused with fully oxygenated arterial blood under normal arterial systolic/diastolic perfusion pressure (see Analysis of Systemic Parameters below), suggesting brain hypoxic changes are related to reductions in brain microcirculation and CBF, rather than to systemic hemodynamic insufficiency. Notably, vascular injury is well established at the 1 month time point in the absence of neuronal changes, thereby suggesting that a primary vascular injury precedes neuronal injury at later time points in pericyte-deficient mice. Significantly, 6-monthold Meox2 +/À mice with an intact BBB ( Figure S4 ), but comparable microvascular reductions and perfusion stress (Wu et al., 2005) as pericyte-deficient F7 mice at the same age, showed a significant reduction in SMI-32-positive neuritic density in the hippocampus CA1 stratum radiatum and cortex and a significant loss of neurons from the hippocampus CA1 stratum pyramidale and cortex by 25% and 19%, and 13% and 14%, respectively, compared to the corresponding values in Meox2 +/+ controls ( Figures 8A-8D ). However, neuronal changes in Meox2 +/À mice were much less pronounced than the reduction in the neuritic length and neuronal loss seen in the same regions of F7 mice that were 50% and 46% and 25% and 26%, respectively, of their corresponding controls (Figures 8A-8D ). These data suggest that perfusion stress alone is sufficient to induce neuronal injury but may act in synergy with accumulated neurotoxins secondary to BBB breakdown to induce even greater injury, as evidenced by more severe neuronal changes in pericyte-deficient mouse models.
Significantly, 1-month-old Pdgfrb +/À mice did not show changes in hippocampal learning and spatial memory determined by novel object location (Mumby et al., 2002) (Figure 6I ) and the perirhinal cortex-mediated consolidation of novel object recognition memory (Winters and Bussey, 2005) (Figure 6J ), consistent with intact neuronal circuitries mediating these behavioral responses at the time point when these mice have accumulated significant vascular damage including BBB breakdown and perfusion deficit. In contrast, 6-to 8-and 14-to 16-month-old Pdgfrb +/À mice had significant impairments on both tests (Figures 6I-6J ). F7 mutants had worse performance on both tests compared to Pdgfrb +/À mice ( Figures 6I-6J ).
To verify functional neuronal integrity in young Pdgfrb +/À mice, we measured local field potentials (LFP) in layer II of the hind limb somatosensory cortex and blood flow responses following electrical stimulation of the hind limb. We did not find significant differences in the LFP amplitude curves in response to an increasing electrical stimulus, LFP peak amplitudes, time-topeak values, and/or LFP signals integrated over the time period of activation (SLFP) between 1-month-old Pdgfrb +/À and Pdgfrb +/+ mice ( Figure S6A-S6F ). On the other hand, there was a significant 23% diminished CBF response in the hind limb somatosensory cortex in 1-month-old Pdgfrb +/À mice compared to controls ( Figure S6G ), corroborating our finding showing reduced CBF response in young Pdgfrb +/À mice after vibrissal stimulation ( Figure 2F ).
Late Neuroinflammatory Response in Pericyte-Deficient Mice
Finally, we studied the role of neuroinflammation. To determine whether the number of microglia is increased, we performed immunostaining for Iba1 (ionized calcium binding adaptor molecule 1), which has been used to study microglial cells in models of neurodegenerative diseases including superoxidedismutase-1 mutant mice (Boillé e et al., 2006) or microglial neurotoxicity (Cardona et al., 2006) . Pdgfrb +/À mice at 1 and 6-8 months did not show a significant neuroinflammatory response (Figure 9 ). At 16 months of age, however, Pdgfrb +/À mice had a significant 2.5-fold increase in the number of microglia displaying a larger ameboid form with stubby processes suggestive of activated microglia compared to the resting microglia with smaller bodies and thinner processes that were found in controls and 1-and 8-month-old Pdgfrb +/À mice ( Figures 9A-9B ). Specific staining for neutrophils (granulocytes) was negative in brains of 1-and 6-to 8-month-old Pdgfrb +/À mice and showed a nonsignificant increase to 1.2 neutrophils per mm 2 in 16-month-old mice ( Figures 9C-9D ). Consistent with microglia activation, 16-month-old, but not 1-and 6-to 8-month-old, Pdgfrb +/À mice exhibited a significant (p < 0.05) increase in the expression of several inflammatory cytokines, including interleukin 1b and 6, tumor necrosis factor-a, monocyte chemoattractant protein-1, and intercellular adhesion molecule 1 (Figures 9E-9I ). , and F7 mice. b-actin was used as a loading control. Graphs show quantification of relative protein abundance with densitometry analysis. Mean ± SEM, n = 6 animals per group; *p < 0.05 or **p < 0.01 by one-way ANOVA. 
Analysis of Systemic Parameters
In all studied genotypes and ages, we have measured hemodynamic and other physiologic parameters including: (1) mean arterial blood pressure from the femoral artery; (2) systolic and diastolic blood pressure; (3) pulse arterial pressure (difference between systolic and diastolic pressure); (4) heart rate; (5) arterial blood gases; (6) arterial pH; (7) serum and CSF glucose levels, and (8) respiration rate. In addition, we have determined in 6-to 8-month-old mice in all genotypes (i.e., Pdgfrb +/+ , Pdgfrb +/À , and F7 mice): (9) liver analyses, and (10) kidney analyses (see Figure S7 ).
These data show no statistical difference in any of the measured hemodynamic, physiological, and/or biochemical parameters including tests for the liver and kidney functions between Pdgfrb +/À and F7 mice compared to age-matched control Pdgfrb +/+ mice, suggesting that pericyte-deficient mice do not have a general perfusion deficit and/or an apparent cardiovascular insufficiency. This indicates that brain perfusion deficits in these mice are mainly of local character.
DISCUSSION
We show that deficient PDGFRb signaling results in pericyte degeneration in the adult and aging brain leading to reductions in brain microcirculation and BBB breakdown prior to neurodegeneration and neuroinflammation (Figure 10 ). Although the mouse lines used in the present study were not pericyte specific, changes in neuronal structure and function in the present pericyte-deficient models on a 129S1/Sv1mJ background cannot be explained by primary neuronal injury because PDGFRb is not expressed in neurons in these mice . Our findings are consistent with previous reports showing that 129SV/C57BL6 mice do not express PDGFRb in neurons or other cell types within the neurovascular capillary unit and that loss of PDGF-B/PDGFRb signaling due to global PDGF-B and/ or PDGFRb knockouts results in vascular damage in the developing CNS mediated by pericyte loss, not neuronal loss (Lindahl et al., 1997; Hellströ m et al., 1999) . Moreover, gene expression profiling on acutely isolated neurons from C57BL6 and C57BL6/DBA mice failed to detect Pdgfrb expression (Cahoy et al., 2008 ; http://innateimmunity.mit.edu/cgi-bin/exonarray/ plot_selector_cahoy.pl).
Other studies have suggested that PDGFRb is expressed in cultured neurons (Zheng et al., 2010) and in the brains of C57BL6 mice and have proposed that higher susceptibility of nestin-Cre + PDGFRb flox/flox mice to cryogenic injury is due to a selective neuronal vulnerability caused by Pdgfrb deletion (Ishii et al., 2006) . The source of the contradictions between these reports remains unclear. It is possible, however, that these conflicting results may reflect genetic differences between mouse strains, consistent with strain-specific gene expression in the adult mouse CNS (Silva et al., 1997; Sandberg et al., 2000) . In addition, cultured neurons do not accurately represent the transcriptional profile of neurons in vivo (Tosh and Slack, 2002; Liu et al., 2007) or of acutely isolated noncultured neurons (Cahoy et al., 2008 mice show a quantitative relationship between an age-dependent progressive pericyte loss and the reductions in brain capillary density, resting CBF and CBF responses to brain activation, and the BBB breakdown associated with brain accumulation of serum proteins and several potentially cytotoxic and/or neurotoxic macromolecules (e.g., fibrin, hemosiderin, thrombin, and plasmin). Vascular, neuronal, and behavioral changes were more pronounced in F7 mice expressing greater pericyte loss than Pdgfrb +/À mice, confirming a key role of pericytes in maintaining integrity of the neurovascular unit. Our findings were quite unexpected given that loss of a single Pdgfrb allele does not result in an apparent vascular phenotype or CNS defects in the developing CNS (Levé en et al., 1994; Soriano, 1994; Lindahl et al., 1997; Tallquist et al., 2003) and that pericytes in the embryonic CNS do not regulate microvessel density and length but are involved in the regulation of endothelial cell number and microvessel architecture (Lindahl et al., 1997; Hellströ m et al., 1999 Hellströ m et al., , 2001 . Although, our data suggest that pericytes may fulfill a different regulatory role with respect to the brain microcirculation during postnatal development and adulthood and during the aging process than previously observed during prenatal embryonic development, the exact contribution of embryonic pericyte loss to the observed (E) The BBB permeability PS product for TMR-dextran (40,000 Da), Cy-3-IgG (150,000 Da), FITC-dextran (MW = 500,000 Da), and fluorescein-conjugated megadextran (MW = 2,000,000 Da) in 6-to 8-month-old Pdgfrb +/+ (white bar), Pdgfrb +/À (black bar), and F7 (gray bar) mice determined by a noninvasive fluorometric tissue analysis not requiring the cranial window surgical procedure. Mean ± SEM, n = 4-6 animals per group. *p < 0.05 or **p < 0.01 by one-way ANOVA. ND is used as an abbreviation for nondetectable. (C-E) Dendritic length (C), dendritic spine density (D), and spine length (E) of Golgi-Cox stained neurons in the CA1 region of the hippocampus in 1, 6-to 8-, and 14-to 16-month-old Pdgfrb +/À mice (black bars) and control Pdgfrb +/+ (white bars) mice, and 6-to 8-month-old F7 mice (gray bars). A total of 30 fields (500 3 375 mm) from three adjacent 100 mm thick sections were analyzed per mouse for dendritic length measurements. A total of 100 randomly selected dendrites from three adjacent 100 mm thick sections were analyzed per mouse for dendritic spine density measurements and for spine length quantification.
(F) Bright-field microscopy analysis of hemotoxylin and eosin staining of stratum pyramidale in the CA1 hippocampal region of 6-month-old Pdgfrb
, and F7 mice.
phenotype is presently unknown. An inducible Cre-loxP-Pdgrfb, or Pdgfrb promoter-dipthera toxin construct, and/or a pericytespecific genetic model with postnatal Pdgfrb deletion with either one being induced in the adult life, may help address: (1) whether loss of pericytes early in the developing CNS (as shown by Tallquist et al., 2003) evolves exponentially over time and becomes the primary force driving the loss of CNS microvascular homeostasis; and (2) whether there is a major difference in the response of the embryonic CNS versus the adult and aging brain to pericyte loss. The feasibility of creating mouse lines with inducible deletion of Pdgfrb gene to address the above questions remains to be determined by future studies.
Deficient PDGF-B/PDGFRb signaling has been shown to initiate pericyte apoptosis leading to vascular regression in animal models of diabetic retinopathy (Geraldes et al., 2009) and tumors (Song et al., 2005) . Cellular accumulation of different toxins such as oxidized glycated low-density lipoproteins (Diffley et al., 2009) , amyloid beta-peptide (Wilhelmus et al., 2007) or advanced glycation end products (Alikhani et al., 2010) can also trigger pericyte apoptosis as shown in pericyte cultures. We show that a deficient PDGFRb signaling in the adult and aging brain in Pdgfrb +/À and F7 mice leads to pericyte-specific insult and apoptosis resulting in microvascular degeneration. Although the mechanism of age-dependent vascular pruning in pericyte-deficient mice is unknown, it may reflect a loss of pericyte-derived trophic support, including vascular endothelial growth factor (Bondjers et al., 2006) . The observed cellular accumulation of serum proteins and cytotoxic macromolecules probably accelerates pericyte degeneration, consistent with in vitro studies.
The exact contributions of perfusion stress and BBB disruption to the development of neurodegenerative changes is not well understood at present. In our study, Meox2 +/À mice with normal pericyte coverage and an intact BBB, but with a substantial perfusion deficit (Wu et al., 2005) comparable to that in pericyte-deficient mice, showed less pronounced changes in neuronal structure than pericyte-deficient mice, indicating that chronic perfusion alone can cause neuronal injury but not to the extent as when combined with the BBB breakdown. Recent findings have suggested that cultured human brain pericytes express low but comparable levels of neurotrophic factors as cultured astrocytes (Shimizu et al., 2010) . Given that the expression and role of pericyte-derived neurotrophic factors in brain in vivo have not been demonstrated and that pericytes do not make direct contacts with neurons (in contrast to astrocytes) (Zlokovic, 2008) , it is unclear at present whether pericyte degeneration can increase neuronal susceptibility to injury through diminished neurotrophic support. Perfusion stress and BBB compromise have been associated with neurodegenerative disorders (Zlokovic, 2008) , including Alzheimer's disease (Iadecola et al., 1999; Deane et al., 2003; Chow et al., 2007; Bell et al., 2009 ) and amyotrophic lateral sclerosis (Zhong et al., 2008 (Zhong et al., , 2009 Rule et al., 2010) . Our work in progress shows that a pericyte-restricted pattern of PDGFRb expression is associated with pericyte loss in Alzheimer's disease (E.A.W., R.D.B., and B.V.Z., unpublished data) indicating that pericytedeficient mice could potentially be used to study the role of brain pericytes in the development of human neurodegenerative conditions such as Alzheimer's disease or amytrophic lateral sclerosis. A temporal sequence of events in the present study suggests that degeneration of vascular pericytes can initiate circulatory insufficiency and BBB disruption first, that is followed by secondary neurodegenerative changes. This vascular concept of neurodegeneration could have broader implications for our understanding of neurological disorders and might guide new therapeutic approaches directed at brain pericytes.
EXPERIMENTAL PROCEDURES Animals
Pdgfrb
+/À and F7 mice were generated as previously described (Tallquist et al., 2003) and kindly provided by Dr. Philippe Soriano. For the Pdgfrb +/À mice, (I and J) Novel object location (I) and novel object recognition (J) exploratory preference in 1-, 6-to 8-, and 14-to 16-month-old Pdgfrb +/À mice (black bars) and age-matched Pdgfrb +/+ control mice (white bars) and in 6-to 8-month-old F7 mice (gray bars) (see Figure S6 ).
In (C-E, G, and I and J), mean ± SEM, n = 6-10 mice per group; *p < 0.05 by one-way ANOVA. NS is used as an abbreviation for nonsignificant. , and F7 mice. A total of 36 and 24 randomly chosen fields (420 3 420 mm) from six nonadjacent cortical and hippocampal sections, respectively, were analyzed per mouse. Mean ± SEM, n = 6 mice per group; *p < 0.05 or **p < 0.01 by one-way ANOVA (see Figure S7 ). a PGKneobpA expression cassette was used to replace a 1.8 kb genomic SmaI-EcoRV fragment spanning sequences coding for the signal peptide to the second immunoglobulin domain of PDGFRb. The F7 mice were generated by point mutations that disrupt the following residues and designated signal transduction pathways: residue 578 (Src), residue 715 (Grb2), residues 739 and 750 (PI3K), residue 770 (RasGAP), and residue 1008 (SHP-2); by changing the tyrosine to phenylalanine, and residue 1020 PLCg, in which the tyrosine was mutated to encode an isoleucine. The Pdgfrb +/À and F7 embryos have a significant (35%-40% and 55%-75%, respectively) reduction in pericytes in the neural tube at the level of heart and kidney in coronal sections at E14.5 (Tallquist et al., 2003) . Meox2 +/À mice were generated as we previously described (Wu et al., 2005) . All mice were maintained on a 129S1/SvlmJ background and were shown to express PDGFRb in the brain exclusively in pericytes . All procedures were approved by the Institutional Animal Care and Use Committee at the University of Rochester with National Institutes of Health guidelines.
Tissue Immunofluorescent and Fluorescent Lectin Staining
Mice were anesthetized intraperitoneally with 100 mg/kg ketamine and 10 mg/kg xylazine and transcardially perfused with phosphate buffer saline (PBS) containing 5 U/ml heparin. Brains were dissected and embedded into optimal cutting temperature (OCT) compound (Tissue-Tek, Torrance, CA) on dry ice. OCTembedded fresh frozen brain tissue sections were cryosectioned at a thickness of 14-18 mm and subsequently fixed in ice cold acetone. Sections were blocked with 5% normal swine serum (Vector Laboratories) for 60 min and incubated in primary antibody diluted in blocking solution overnight at 4 C. Sections were washed in PBS and incubated with fluorophore-conjugated secondary antibodies. To visualize brain microvessels in specified experiments, sections were also incubated with biotin-or fluorescein-conjugated L. esculentum lectin (Vector Laboratories). Sections were subsequently coverslipped with fluorescent mounting medium (Dako). For a detailed description of all primary antibodies, secondary antibodies, and lectins used for detection of pericytes (PDGFRb, NG2, and desmin), endothelial cells (CD31 and lectin), neurons (SMI-32 and NeuN), microglia (Iba1), astrocytes (AQP4, a-syntrophin, and GFAP), and other proteins (IgG, fibrin, thrombin, plasmin, and laminin), please refer to Supplemental Experimental Procedures.
TUNEL
Paraformaldhyde-fixed, paraffin-embedded brain tissue sections were sectioned at a thickness of 7 mm. Immuofluorescent detection of pericytes (PDGFRb) or neurons (NeuN) and/or endothelial-specific lectin fluorescent detection was conducted as described above. The DeadEnd Fluorometric TUNEL system (Promega) was then completed as described by the manufacturer. Sections were coverslipped as described above. 
Confocal Microscopy Analysis
Bright-Field Microscopy Analysis
Imaging and quantification of hematoxylin and eosin stained sections, Prussian blue-positive extravascular hemosiderin deposits, neuronal Golgi-Cox staining for determination of dendritic length and dendritic spine density and length, Iba1-positive microglia and neutrophil-specific dichloracetate esterase staining was conducted with an Olympus AX70 bright-field microscope and the NIH ImageJ software, respectively. For a detailed description of each technique and subsequent analysis, where applicable, please refer to Supplemental Experimental Procedures.
Multiphoton In Vivo Microscopy Analysis
In vivo multiphoton experiments were performed as we previously described Zhu et al., 2010 In (B and D), a total of 36 and 24 randomly chosen fields (420 3 420 mm) from six nonadjacent cortical and hippocampal sections, respectively, were analyzed per mouse. Mean ± SEM, n = 6 mice per group; *p < 0.05 or **p < 0.01 by one-way ANOVA.
a 900 nm mode-locked femtosecond pulsed DeepSee Ti:Sapphire laser (Spectra-Physics, Newport) with a Zeiss 203/1.0 M27 W dipping objective. The 900 nm multiphoton laser excited fluorescein or TMR and the emission was collected with a 500-550 nm or 560-615 nm band pass filter, respectively. Perfused Capillary Length Fluorescein-conjugated mega-dextran (2,000,000 Da, Invitrogen, 0.1 ml of 10 mg/ml) was injected via the left femoral vein. Multiphoton Z stack images were immediately taken through the cranial window starting at 50 mm below the cortical brain surface continuing to scan 500 mm deep through cortical layers II and III with a 1 mm interval in between each image acquisition. Z stacks were maximally projected and reconstructed with ZEN software (Carl Zeiss Microimaging). The perfused capillary length was analyzed with the National Institutes of Health ImageJ software. For detailed description of the analysis and rationale of using single time point analysis please refer to Supplemental Experimental Procedures.
BBB Permeability
Cortical cerebrovascular permeability was determined with rapid in vivo multiphoton microscopy imaging as we previously described (Zhu et al., 2010) . In brief, TMR-conjugated medium-size dextran (40,000 Da, Invitrogen, 0.1 ml of 10 mg/ml) was injected via the left femoral vein. In vivo time-lapse images were acquired every 2 min for a total of 30 min. All images were subjected to threshold processing and the extravascular fluorescent intensity was measured with the integrated density measurement function by a blinded investigator. The in vivo BBB permeability for TMR-dextran was estimated as the PS product as we previously described (Deane et al., 2003; Zhu et al., 2010) with the following formula: PS = (1-Hct) 1/Iv 3 V x dIt/dt, where Hct is the hematocrit (45%), Iv is the initial fluorescence intensity of the region of interest (ROI) within the vessel, It is the intensity of the ROI within the brain at time t, V is the vessel volume, and assuming 1 g of brain is equivalent to 50 cm 2 . See Supplemental Experimental Procedures for details.
Noninvasive Fluorometric BBB Permeability Measurements
The BBB permeability to different size tracers including TMR-dextran (MW = 40,000 Da; Invitrogen), Cy3-IgG (MW = 150,000 Da; Invitrogen), FITCdextran (MW = 500,000 Da; Sigma), and fluorescein-mega-dextran (MW = 2,000,000 Da; Invitrogen) was assessed in the cortex and hippocampus of anesthetized mice (100 mg/kg ketamine and 10 mg/kg xylazine, intraperitoneally) with a noninvasive fluorometric technique. In brief, these tracers were injected intravenously via the femoral vein and blood and brain samples were collected within 30 min. Plasma samples and homogenized brain regions were analyzed with a fluorometric plate reader (Victor) to determine tracer concentration. The BBB PS product (ml/g/min) was calculated by using the equation as we described (Mackic et al., 1998) 
Quantitative 14 C-iodoantipyrine Autoradiography
Mice were anesthetized with 2%-3% isoflurane in 30% oxygen/70% nitrous oxide. Local CBF was measured by using intraperitoneal injection of radiolabeled 14 C-iodoantipyrine (IAP) and a single blood sampling from the heart at the end of the experiment, as we previously described (Zhong et al., 2008) . Blood flow, F (ml/100 g/min), was calculated by using the equation, as we described (Zhong et al., 2008) : to the value measured in the blood sample from the frozen heart at the end of the experiment (at time T), by assuming a linear rise or ramp function over T; l is 14 C-IAP central nervous system tissue to blood partition coefficient, 0.8 ml/g. Arterial blood pressure, pH, and blood gases were monitored before 14 C-IAP administration. There were no significant changes in these physiological parameters between Pdgfrb +/À or F7 mutants compared
to Pdgfrb +/+ control mice. See for details Supplemental Experimental
Procedures.
Laser Doppler Flowmetry CBF responses to vibrissal stimulation in anesthetized mice (750 mg/kg urethane and 50 mg/kg chloralose) were determined with laser Doppler flowmetry, as previously described (Iadecola et al., 1999; Chow et al., 2007; Bell et al., 2009) . The tip of the laser Doppler probe (Transonic Systems) was stereotaxically placed 0.5 mm above the dura of the cranial window. The right vibrissae was cut to about 5 mm and stimulated by gentle stroking at 3-4 Hz for 1 min with a cotton-tip applicator. The percentage increase in CBF due to vibrissal stimulation was obtained from the baseline CBF and stable maximum plateau and averaged for the three trials. Arterial blood pressure was monitored continuously during the experiment. pH and blood gases were monitored before and after CBF recordings. No significant changes in these physiological parameters were found between different genotypes and ages. In a separate set of experiments, CBF responses were determined in the somatosensory cortex hind limb region following electrical stimulation of the hind limb with a 2 mA 0.5 s long stimulus.
Immunoblotting Analysis Isolated brain capillaries and capillary-depleted brains were prepared as we previously described. See Supplemental Experimental Procedures for details.
Immunoblotting studies for the tight junction proteins (ZO-1, occludin, and claudin-5) and vascular basement membrane proteins (laminin and collagen IV) in brain capillary homogenates and for blood-derived plasma proteins (thrombin and plasmin) in capillary-depleted brain homogenates were performed with primary antibodies as described in Supplemental Experimental Procedures. The relative abundance of studied proteins in microvessels and capillary-depleted brains was determined with scanning densitometry and b-actin as a loading control.
Behavior
Mice were subjected to novel object location and recognition behavioral tests. The novel object location and recognition tests were performed as previously described (Mumby et al., 2002; Winters and Bussey, 2005) . For a detailed description please refer to Supplemental Experimental Procedures.
Electrophysiologic Recordings
In vivo, extracellular electrophysiologic recordings were carried out in urethane anesthetized mice to quantify LFP amplitude, time-to-peak values, and LFP signals integrated over the time period of activation (SLFP) in layer II of the hind limb somatosensory cortex following electrical stimulation of the contralateral hind limb. For a detailed description please refer to Supplemental Experimental Procedures.
Neuroinflammation
In addition to quantifying Iba1-positive microglia and neutrophil-specific dichloracetate esterase staining, we analyzed relative abundance of several neuroinflammatory cytokines/chemokines through quantitative real-time PCR with RNA isolated from snap-frozen brain samples as we previously described (Zhong et al., 2009) . Gene expression was normalized to the housekeeping gene Gapdh. For cytokine/chemokine primer sequences please refer to Supplemental Experimental Procedures.
Systemic Parameters
We have performed measurements of several hemodynamic, physiological, and biochemical parameters, including tests for liver and kidney functions. For a detailed description please refer to Supplemental Experimental Procedures.
Statistical Analysis
Data were analyzed by multifactorial analysis of variance (ANOVA) followed by Tukey post-hoc tests and Pearson's correlation analysis. A p value less than 0.05 was considered statistically significant. (D) The number of neutrophils in the cortex of 1-, 6-to 8-, and 14-to 16-month-old Pdgfrb +/À mice and mice receiving the MCAO compared to control 1-month-old Pdgfrb +/+ mice.
(E-I) Real-time quantitative PCR for mouse interlukein-1 beta (Il-1b) (E), interlukein 6 (Il-6) (F), tumor necrosis factor alpha (Tnf-a) (G), chemokine C-C motif ligand 2 (Ccl2)(H), and intercellular adhesion molecule 1 (Icam-1) (I) mRNA in the cerebral cortex of 1-, 6-to 8-, and 14-to 16-month-old Pdgfrb +/À (black bars) and agematched control Pdgfrb +/+ (white bars) mice.
In (B, D, and E-I), mean ± SEM, n = 4-6 mice per group; *p < 0.05 by one-way ANOVA. NS is used as an abbreviation for nonsignificant. PDGFRb-deficient signaling in brain pericytes leads to a progressive age-dependent pericyte loss resulting in (1) reductions in brain microcirculation with diminished CBF and CBF responses to a stimulus (CBF dysregulation), leading to a chronic perfusion stress and hypoxia, and (2) BBB breakdown with accumulation of serum proteins and several cytotoxic and neurotoxic pathologic deposits in brain. Both arms 1 and 2 may contribute to secondary neuronal injury and neurodegeneration mediated by a neurovascular insult.
